Rocket Lab NASDAQ: RKLB reported its Q2 2026 results after the close on Monday, Aug. 11, and by almost every operational measure, it was the strongest quarter in the company's history. Record revenue, a record backlog, more than $1 billion in new contracts, and continued progress toward Neutron's debut. Yet the stock slipped in after-hours trading, changing hands almost 8% lower. For a report this strong, the reaction reflects more on expectations than on execution.
A Record Quarter Across the Board
Rocket Lab Today
$78.58 -1.46 (-1.82%) As of 12:16 PM Eastern
This is a fair market value price provided by Massive. Learn more. - 52-Week Range
- $37.57
▼
$151.00 - Price Target
- $110.65
Revenue came in at a record $234 million, up 62% year over year and 16.8% sequentially, topping the consensus estimate. It was the second straight quarter of record revenue, driven by strength across both business segments. The company reported a loss of 8 cents per share, below the estimate of 6 cents. Product revenue nearly doubled to $181.3 million from $92.7 million a year earlier, reflecting the growing contribution of the Space Systems business, which now includes the Mynaric and Motiv acquisitions.
The backlog told an even more striking story. It surged 137% to a record $2.36 billion, split roughly 40% Launch Services and 60% Space Systems. The company signed more than $1 billion in new contracts across the quarter and the period just after it, including over $437 million in new launch bookings across Electron, HASTE, and Neutron. Rocket Lab now has more than 90 missions on its manifest, the highest in company history. Net loss narrowed to $49 million, an improvement year over year, though the company remains unprofitable as it continues to pour capital into Neutron.
Guidance Points to Another Record, With a Margin Caveat
For Q3, Rocket Lab guided to revenue of $250 million to $265 million, which would mark yet another record and represent continued sequential growth. That is the good news. The more nuanced part is on profitability. The company guided to non-GAAP gross margins of 35% to 37%, softer than the level it just delivered, and an adjusted EBITDA loss of $17 million to $23 million.
Management was direct about the reason: cash usage will remain elevated because Neutron development, infrastructure investment, and acquisition integration are all drawing on resources simultaneously. In other words, the top line keeps setting records, but the path to profitability runs through a heavy investment phase first. That margin guidance, together with Neutron commentary, is the most likely explanation for the after-hours dip.
Neutron Remains the Main Event
As always with Rocket Lab, the single most important variable is Neutron, and management held the line on its timeline...sort of. Flight hardware is moving toward final assembly and integration at Launch Complex 3 in Virginia, and the company continues to target delivery of the rocket to the pad in the fourth quarter of 2026. CEO Peter Beck did acknowledge that the window for an end-of-year launch is narrowing, an honest note investors will weigh carefully. Beck emphasized that the priority is not just the first flight but reaching a sustained launch cadence and scalability, beginning with its first flight.
Importantly, Neutron already has customers waiting. The $397 million contract SB-AMTI award announced Aug. 4 names Neutron as its launch vehicle, and Beck noted that demand across the launch business is "extreme," citing more than $437 million in bookings for Electron, HASTE, and Neutron. On pricing, CFO Adam Spice said the company is holding firm on Neutron's $50 million to $55 million average selling price, declining to discount early launches, a sign of confidence in demand.
A New Launch System and Continued Expansion
The quarter also brought a new product announcement. Rocket Lab introduced GHOST, a globally deployable launch system designed to support suborbital and orbital launches from anywhere in the world. Its first location will be at the Pacific Spaceport Complex in Kodiak, Alaska. The move underscores the company's push to expand its launch footprint and cadence, complementing its ongoing Electron business and the pending $8 billion Iridium acquisition, which would further transform it into a vertically integrated space company with a recurring-revenue satellite network.
Where Things Stand for Rocket Lab
Rocket Lab Stock Forecast Today
12-Month Stock Price Forecast:$110.6538.24% UpsideModerate BuyBased on 22 Analyst Ratings | Current Price | $80.04 |
|---|
| High Forecast | $150.00 |
|---|
| Average Forecast | $110.65 |
|---|
| Low Forecast | $60.00 |
|---|
Rocket Lab Stock Forecast DetailsThe setup after this report is a familiar one for Rocket Lab. The business is executing at the highest level in its history, with record revenue, a record backlog approaching $2.4 billion, and Neutron inching toward the pad.
Yet the stock still trades at a premium valuation and remains unprofitable, which is why softer margin guidance was enough to prompt a dip even alongside a clear revenue beat.
The consensus rating sits at Moderate Buy, with an average price target of $111.82, implying meaningful upside from current levels.
For long-term investors, the thesis is intact and arguably strengthening: demand is extreme, the backlog is compounding, and Neutron is drawing marquee customers before it has even flown.
The question is the same one it has been all year. Can execution on Neutron and margins eventually catch up to the extraordinary growth in bookings?

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.